Quote:
Originally Posted by pcstock Jerico,
SKVI went up today. I wonder whether this technology can be easily adapted to mutation of H1N1 and other virus and whether it is economically enough for the general public to use. Having patents in Asia like China has a good potential if SKVI products can become a must have personal item. |
PCStock,
According to the Skinvisible website their DermSafe product is effective on a number of viruses (virii?), including;
"Staphylococcus aureus (MRSA), Escherichia coli, and Pseudomonas aeruginosa, as well as Type A Influenza viruses that include H1N1 ("swine flu") and H3N2; Influenza A, subtype H5N1 virus; commonly known as "avian influenza" or "bird flu"; Influenza B virus; Hepatitis C virus as well as Clostridium difficile, (C. difficile). Study results showing H1N1, H3N2 and Influenza B..."
With only 84.6 million shares outstanding & 10% owned by insiders this will start to rocket very soon. Volume today was 1.6m shares & will soon pick up now that they have been 'discovered'.